Compile Data Set for Download or QSAR
maximum 50k data
Found 274 of ic50 for UniProtKB: P49862
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336124(US9744148, 1)
Affinity DataIC50:  39nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM32709((5-amino-3-pyridin-3-yl-1,2,4-triazol-1-yl)-(4-met...)
Affinity DataIC50:  40nMAssay Description:Inhibition of human kallikrein 7 measured after 15 mins at pH 8 by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113069(US9695194, 5)
Affinity DataIC50:  48nMAssay Description:Inhibition of recombinant human KLK7 using S-2586 substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM50460879(CHEMBL4228441)
Affinity DataIC50:  48nMAssay Description:Inhibition of recombinant human KLK7 using MOCAc-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 10 mins followed by s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM50275974(CHEMBL4126936)
Affinity DataIC50:  58nMAssay Description:Inhibition of recombinant human KLK7 using MOCAc-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 10 mins followed by s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM50275974(CHEMBL4126936)
Affinity DataIC50:  58nMAssay Description:Inhibition of recombinant human C-terminal His10-tagged KLK7 (E23 to H252 residues) using MOCAcArg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as su...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336128(US9744148, 2)
Affinity DataIC50:  70nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336129(US9744148, 3)
Affinity DataIC50:  80nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336130(US9744148, 4)
Affinity DataIC50:  80nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336132(US9744148, 5)
Affinity DataIC50:  90nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM50460884(CHEMBL4228178)
Affinity DataIC50:  110nMAssay Description:Inhibition of recombinant human KLK7 using MOCAc-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 10 mins followed by s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336133(US9744148, 6)
Affinity DataIC50:  120nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336134(US9744148, 7)
Affinity DataIC50:  130nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336135(US9744148, 8)
Affinity DataIC50:  140nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336137(US9744148, 10 | US9744148, 31)
Affinity DataIC50:  150nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336136(US9744148, 9)
Affinity DataIC50:  150nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336138(US9744148, 11)
Affinity DataIC50:  150nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336142(US9744148, 12 | US9744148, 23)
Affinity DataIC50:  150nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336143(US9744148, 13)
Affinity DataIC50:  170nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336145(US9744148, 14)
Affinity DataIC50:  180nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336146(US9744148, 15)
Affinity DataIC50:  180nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336147(US9744148, 16)
Affinity DataIC50:  190nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336148(US9744148, 17)
Affinity DataIC50:  190nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM33882((5-amino-3-pyridin-3-yl-1,2,4-triazol-1-yl)-(4-chl...)
Affinity DataIC50:  220nMAssay Description:Inhibition of human kallikrein 7 measured after 15 mins at pH 8 by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336149(US9744148, 18)
Affinity DataIC50:  220nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336150(US9744148, 19)
Affinity DataIC50:  230nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM33437((5-amino-3-phenyl-1,2,4-triazol-1-yl)-(3,4-dimetho...)
Affinity DataIC50:  230nMAssay Description:Inhibition of human kallikrein 7 measured after 15 mins at pH 8 by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336151(US9744148, 20)
Affinity DataIC50:  230nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336152(US9744148, 21)
Affinity DataIC50:  260nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336153(US9744148, 22)
Affinity DataIC50:  260nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336142(US9744148, 12 | US9744148, 23)
Affinity DataIC50:  270nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336155(US9744148, 24)
Affinity DataIC50:  280nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336156(US9744148, 25)
Affinity DataIC50:  310nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336157(US9744148, 26)
Affinity DataIC50:  320nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336158(US9744148, 27)
Affinity DataIC50:  330nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336159(US9744148, 28)
Affinity DataIC50:  340nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336160(US9744148, 29)
Affinity DataIC50:  350nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336161(US9744148, 30)
Affinity DataIC50:  360nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336137(US9744148, 10 | US9744148, 31)
Affinity DataIC50:  370nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336163(US9744148, 32)
Affinity DataIC50:  380nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336165(US9744148, 34)
Affinity DataIC50:  390nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336164(US9744148, 33)
Affinity DataIC50:  390nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM50518308(CHEMBL4554224)
Affinity DataIC50:  390nMAssay Description:Inhibition of thermolysin activated recombinant human C-terminal 10-His tagged KLK7 (E23 to H252 residues) using MOCAc-Arg-Pro-Lys-Pro-Val-Glu-Nva-Tr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336166(US9744148, 35)
Affinity DataIC50:  410nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336167(US9744148, 36)
Affinity DataIC50:  430nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM50460875(CHEMBL4227658)
Affinity DataIC50:  450nMAssay Description:Inhibition of recombinant human KLK7 using MOCAc-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 as substrate preincubated for 10 mins followed by s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336168(US9744148, 37)
Affinity DataIC50:  460nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336169(US9744148, 38)
Affinity DataIC50:  470nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM336170(US9744148, 39)
Affinity DataIC50:  480nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM50459539(CHEMBL4206734)
Affinity DataIC50: >500nMAssay Description:Inhibition of KLK7 (unknown origin) expressed in Pichia pastoris pre-incubated for 10 mins before Leu-Leu-Val-Tyr-AMC substrate addition and measured...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 274 total ) | Next | Last >>
Jump to: